120 related articles for article (PubMed ID: 34276260)
21. The potential of health sector non-governmental organizations: policy options.
Gilson L; Sen PD; Mohammed S; Mujinja P
Health Policy Plan; 1994 Mar; 9(1):14-24. PubMed ID: 10133097
[TBL] [Abstract][Full Text] [Related]
22. Practices of care among people who buy, use, and sell drugs in community settings.
Kolla G; Strike C
Harm Reduct J; 2020 May; 17(1):27. PubMed ID: 32381011
[TBL] [Abstract][Full Text] [Related]
23. Research led by people who use drugs: centering the expertise of lived experience.
Salazar ZR; Vincent L; Figgatt MC; Gilbert MK; Dasgupta N
Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):70. PubMed ID: 34544478
[TBL] [Abstract][Full Text] [Related]
24. Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study.
Gehring ND; Speed KA; Wild TC; Pauly B; Salvalaggio G; Hyshka E
Int J Drug Policy; 2022 Oct; 108():103805. PubMed ID: 35907373
[TBL] [Abstract][Full Text] [Related]
25. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
26. Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA.
Torres-Leguizamon M; Favaro J; Coello D; Reynaud EG; Néfau T; Duplessy C
Harm Reduct J; 2023 Jan; 20(1):1. PubMed ID: 36611167
[TBL] [Abstract][Full Text] [Related]
27. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.
Russell C; Ali F; Nafeh F; LeBlanc S; Imtiaz S; Elton-Marshall T; Rehm J
BMC Public Health; 2021 Nov; 21(1):2021. PubMed ID: 34742267
[TBL] [Abstract][Full Text] [Related]
28. The Middle East and COVID-19: time for collective action.
Fawcett L
Global Health; 2021 Nov; 17(1):133. PubMed ID: 34809646
[TBL] [Abstract][Full Text] [Related]
29. Development assistance for health and the Middle East and North Africa.
Zhao Y; Micah AE; Gloyd S; Dieleman JL
Global Health; 2020 Feb; 16(1):14. PubMed ID: 32019554
[TBL] [Abstract][Full Text] [Related]
30. Influenza vaccination situation in Middle-East and North Africa countries: Report of the 7th MENA Influenza Stakeholders Network (MENA-ISN).
; Al Awaidi S; Abusrewil S; AbuHasan M; Akcay M; Aksakal FNB; Bashir U; Elahmer O; Esteghamati A; Gahwagi M; Mirza YK; Grasso C; Kassianos G; Khris M; Mardani M; Maltezou H; Nourlil J; Oumzil H; Osterhaus A; Picot V; Pehlivan T; Saadatian-Elahi M; Tali İ; Tarraf H; Ugur B; Zaraket H;
J Infect Public Health; 2018; 11(6):845-850. PubMed ID: 30126699
[TBL] [Abstract][Full Text] [Related]
31. Substance use policy and practice in the COVID-19 pandemic: Learning from early pandemic responses through internationally comparative field data.
Aronowitz SV; Carroll JJ; Hansen H; Jauffret-Roustide M; Parker CM; Suhail-Sindhu S; Albizu-Garcia C; Alegria M; Arrendondo J; Baldacchino A; Bluthenthal R; Bourgois P; Burraway J; Chen JS; Ekhtiari H; Elkhoy H; Farhoudian A; Friedman J; Jordan A; Kato L; Knight K; Martinez C; McNeil R; Murray H; Namirembe S; Radfar R; Roe L; Sarang A; Scherz C; Tay Wee Teck J; Textor L; Thi Hai Oanh K
Glob Public Health; 2022 Dec; 17(12):3654-3669. PubMed ID: 36692903
[TBL] [Abstract][Full Text] [Related]
32. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
[TBL] [Abstract][Full Text] [Related]
33. Developing a digital health strategy for people who use drugs: Lessons from COVID-19.
Perri M; Guta A; Gagnon M; Bonn M; Leece P; Bayoumi AM; Rai N; Touesnard N; Strike C
Digit Health; 2021; 7():20552076211028404. PubMed ID: 34262782
[TBL] [Abstract][Full Text] [Related]
34. The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries.
Maticic M; Pirnat Z; Leicht A; Zimmermann R; Windelinck T; Jauffret-Roustide M; Duffell E; Tammi T; Schatz E
Harm Reduct J; 2020 Nov; 17(1):89. PubMed ID: 33213481
[TBL] [Abstract][Full Text] [Related]
35. Impact of COVID-19 pandemic on psychological wellbeing of Oncology clinicians in the Middle East and North Africa (MENA) region.
Azam F; Latif MF; Bashir S; Tirmazi SH; Bukhari N; Al-Selwi W; AlShamsi HO; Ibnshamsah F; Zekri J
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):1049-1055. PubMed ID: 35179772
[TBL] [Abstract][Full Text] [Related]
36. Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada.
Minoyan N; Høj SB; Zolopa C; Vlad D; Bruneau J; Larney S
Harm Reduct J; 2022 Apr; 19(1):38. PubMed ID: 35436936
[TBL] [Abstract][Full Text] [Related]
37. The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.
Mahmud S; Mumtaz GR; Chemaitelly H; Al Kanaani Z; Kouyoumjian SP; Hermez JG; Abu-Raddad LJ
Addiction; 2020 Jul; 115(7):1244-1262. PubMed ID: 32009283
[TBL] [Abstract][Full Text] [Related]
38. Harm Reduction and Adaptations Among PWUD in Rural Oregon During COVID-19.
Seaman A; Leichtling G; Stack E; Gray M; Pope J; Larsen JE; Leahy JM; Gelberg L; Korthuis PT
AIDS Behav; 2021 May; 25(5):1331-1339. PubMed ID: 33471243
[TBL] [Abstract][Full Text] [Related]
39. Hospital policy as a harm reduction intervention for people who use drugs.
Lennox R; Martin L; Brimner C; O'Shea T
Int J Drug Policy; 2021 Nov; 97():103324. PubMed ID: 34153628
[TBL] [Abstract][Full Text] [Related]
40. Harm reduction social work with people who use drugs: a qualitative interview study with social workers in harm reduction services in Sweden.
Richert T; Stallwitz A; Nordgren J
Harm Reduct J; 2023 Oct; 20(1):146. PubMed ID: 37833801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
